CNS complications during treatment of acute lymphoblastic leukemia/lymphoblastic lymphoma
Piali Mandal, Puneet Kaur Sahi, Preetam Meena, Deepti Verma, Aditi Jain, Varinder Pal Singh, Jagdish Chandra
Abstract
Open-access reader
Piali Mandal, Puneet Kaur Sahi, Preetam Meena, Deepti Verma, Aditi Jain, Varinder Pal Singh, Jagdish Chandra
Abstract
Open-access reader
patients with T-ALL developed a CNS relapse, of which one had CNS leukemia at diagnosis and the other eventually developed a combined bone marrow and CNS relapse.Conclusion: In conclusion, pCRT can be avoided in most children with ALL including those with T-cell immunophenotype.Our results demonstrate an excellent CNS control of leukemia just by using IT performed by strict adherence to recommended protocols.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
patients with T-ALL developed a CNS relapse, of which one had CNS leukemia at diagnosis and the other eventually developed a combined bone marrow and CNS relapse.Conclusion: In conclusion, pCRT can be avoided in most children with ALL including those with T-cell immunophenotype.Our results demonstrate an excellent CNS control of leukemia just by using IT performed by strict adherence to recommended protocols.
Key concepts: Medicine, Lymphoblastic Leukemia, Lymphoblastic lymphoma, Lymphoma, Oncology, Cancer research, Immunology, Leukemia